SELP and neoplasm: During the TCIPA process, platelet αIIbβ3, α6β1, platelet P-selectin, platelet Toll-like receptor (TLR) 4 and platelet CLEC-2 bind to protein molecules on the surface of the corresponding tumor cells, enhancing platelet activation and tumor cell malignant behavior (36, 39–42).